Public Profile

Xiwang Pharmaceutical Co., Ltd.

Xiwang Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. Xiwang Pharmaceutical is renowned for its commitment to innovation and quality, offering a diverse range of products that cater to both domestic and international markets. The company has achieved significant milestones, including certifications from global regulatory bodies, which underscore its dedication to maintaining high standards. With a strong market position, Xiwang continues to expand its footprint, contributing to advancements in healthcare and improving patient outcomes worldwide.

DitchCarbon Score

How does Xiwang Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Xiwang Pharmaceutical Co., Ltd.'s score of 0 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

20%

Xiwang Pharmaceutical Co., Ltd.'s reported carbon emissions

Xiwang Pharmaceutical Co., Ltd., headquartered in China, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess the company's climate impact or its strategies for addressing carbon emissions. In the pharmaceutical industry, companies are increasingly expected to adopt robust climate commitments and set measurable targets to reduce their carbon footprint. However, as of now, Xiwang Pharmaceutical has not disclosed any such information.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Xiwang Pharmaceutical Co., Ltd.'s primary industry is Financial intermediation services, except insurance and pension funding services (65), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Xiwang Pharmaceutical Co., Ltd. is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Xiwang Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Financial Intermediation

Index Ventures

CH
Financial Intermediation
Updated 11 days ago

Payroll Specialists Association

AU
Financial Intermediation
Updated 11 days ago

LAPORTE CONSULTANTS

US
Financial Intermediation
Updated 11 days ago

Macao Electric Lighting

HK
Financial Intermediation
Updated 11 days ago
CDP

Idfc First Bank

IN
Financial Intermediation
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers